Discover and read the best of Twitter Threads about #CPRA
Most recents (4)
My observations on @AGRobBonta's first major #CCPA enforcement action, announced today against @Sephora - big news for U.S. privacy. 1/16
✨Complaint: oag.ca.gov/system/files/a…
✨Settlement: oag.ca.gov/system/files/a…
✨Complaint: oag.ca.gov/system/files/a…
✨Settlement: oag.ca.gov/system/files/a…
First, @Sephora is a strategic choice. The most significant outcome is their 2-yr agreement to honor Global Privacy Control (GPC) signals. It's very important for the AG to get this on the books, because it bolsters CCPA's key (only) redeeming feature: the universal opt-out. 2/
Despite CCPA's underlying weaknesses (advocates have rightly criticized it as an ineffectual notice & choice law), the concept of a decentralized "universal opt-out" browser mechanism has taken hold in the US and been adopted in CO, CT - with great promise. 3/
1/24 My second big win in court against a charter school corporation. It was also a major victory over their #CCSA trade association, which tried to use this case to carve out immunity to the #CPRA. I represented @DotKohlhaas in this action. @DianeRavitch
2/24 My first win was a year ago as third chair in a suit to overturn a wrongful expulsion of a student of color. The PUC charter chain (of convicted felon Ref Rodriguez fame) violated that student's due process rights. Violated isn't a strong enough word for what they did.
3/24 PUC unilaterally changed the charges at the appeals hearing and branded the child as a terrorist in his permanent record. Under the tutelage of the brilliant partners at the firm (lawyer4children.com), plus sage advice from @DrPrestonGreen, we built a strong case.
Q7 #CPRA seeks to protect a new class of personal information, known as “sensitive personal information.” What should #CISOs do to prepare for this new reality?
A7 CISOs should review the list of elements included in this new class, confer with the organization’s privacy leader, and determine what, if any, new controls need to be added. --Scott
@threadreaderapp unroll
1/ A continuation #tweetorial from my last one introducing human leukocyte antigen (#HLA) , the cell surface antigen...
Below, let's briefly review basics of #Luminex testing & "cross-matching."
What/who is Luminex?
Below, let's briefly review basics of #Luminex testing & "cross-matching."
What/who is Luminex?
2/ In this #tweetorial, we'll answer 3Qs that help us assess a #kidneytransplant recipient's immunological risk:
1. Does this recipient have #DSA* (against HLA-antigens) ?
2. Can the antibodies bind?
3. Can the antibodies activate complement?
*DSA: donor specific antibodies
1. Does this recipient have #DSA* (against HLA-antigens) ?
2. Can the antibodies bind?
3. Can the antibodies activate complement?
*DSA: donor specific antibodies
